Human pluripotent stem cell-derived cardiac stromal cells and their applications in regenerative medicine
2020
Martha E. Floy | Taylor D. Mateyka | Koji L. Foreman | Sean P. Palecek
Coronary heart disease is one of the leading causes of death in the United States. Recent advances in stem cell biology have led to the development and engineering of human pluripotent stem cell (hPSC)-derived cardiac cells and tissues for application in cellular therapy and cardiotoxicity studies. Initial studies in this area have largely focused on improving differentiation efficiency and maturation states of cardiomyocytes. However, other cell types in the heart, including endothelial and stromal cells, play crucial roles in cardiac development, injury response, and cardiomyocyte function. This review discusses recent advances in differentiation of hPSCs to cardiac stromal cells, identification and classification of cardiac stromal cell types, and application of hPSC-derived cardiac stromal cells and tissues containing these cells in regenerative and drug development applications.
Show more [+] Less [-]Bibliographic information
This bibliographic record has been provided by Directory of Open Access Journals